| 前收盘价格 | 2.80 |
| 收盘价格 | 2.80 |
| 成交量 | 966,566 |
| 平均成交量 (3个月) | 914,587 |
| 市值 | 310,598,880 |
| 价格/销量 (P/S) | 9.42 |
| 股市价格/股市净资产 (P/B) | 1.85 |
| 52周波幅 | |
| 利润日期 | 11 Aug 2025 - 15 Aug 2025 |
| 营业利益率 (TTM) | -583.86% |
| 稀释每股收益 (EPS TTM) | -11.24 |
| 总债务/股东权益 (D/E MRQ) | 18.94% |
| 流动比率 (MRQ) | 3.73 |
| 营业现金流 (OCF TTM) | -291.17 M |
| 杠杆自由现金流 (LFCF TTM) | -169.99 M |
| 资产报酬率 (ROA TTM) | -101.07% |
| 股东权益报酬率 (ROE TTM) | -247.04% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Alumis Inc. | 看跌 | - |
AIStockmoo 评分
0.3
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.5 |
| 平均 | 0.25 |
|
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 0.63% |
| 机构持股比例 | 53.94% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Ayurmaya Capital Management Company, Lp | 31 Mar 2025 | 15,139,707 |
| Foresite Capital Management V, Llc | 31 Mar 2025 | 5,779,348 |
| Venbio Partners Llc | 31 Mar 2025 | 4,619,804 |
| Sr One Capital Management, Lp | 31 Mar 2025 | 1,959,896 |
| Velan Capital Investment Management Lp | 31 Mar 2025 | 1,620,847 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 25.00 (Oppenheimer, 730.57%) | 购买 |
| 中 | 18.00 (498.01%) | |
| 低 | 14.00 (HC Wainwright & Co., 365.12%) | 购买 |
| 平均值 | 19.00 (531.23%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 4.28 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Guggenheim | 10 Jun 2025 | 18.00 (498.01%) | 购买 | 3.36 |
| Oppenheimer | 15 May 2025 | 25.00 (730.56%) | 购买 | 5.35 |
| HC Wainwright & Co. | 30 Apr 2025 | 14.00 (365.12%) | 购买 | 4.14 |
| 22 Apr 2025 | 14.00 (365.12%) | 购买 | 4.97 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合